The Truth About the Status of Covid-19; the Effectiveness of HCQ & Novel Treatment Approaches

The good news is that Covid-19 is losing its epidemic status because of the continuing decline in the number of deaths from |Covid-19 and pneumonia, as confirmed by the  CDC on July 3rd:

“Based on death certificate data, the percentage of deaths attributed to pneumonia, influenza or COVID-19 (PIC) decreased from 9.0% during week 25 to 5.9% during week 26, representing the tenth week of a declining percentage of deaths due to PIC.” If the percentage continues to decline, it is likely COVID-19 will lose its classification as an epidemic in the next few weeks.”

Dr. Fauci’s response to the confirmation that Covid-10 deaths are receding was:

It’s a false narrative to take comfort in a lower rate of death.

This shocking response was reiterated by the complicit mainstream media: The Washington Post, Chicago Tribune, Newsday and Bloomberg News – which declared: “A Lower COVID-19 Death Rate Is Nothing to Celebrate“.

This is not the first time that Dr. Fauci expressed, what can only be considered a hostile view toward a positive development that would lead to normalization. On April 6, 2020, at a White House coronavirus briefing Dr. Fauci stated:

  •  What is the hidden agenda behind these clearly bizarre dissonant responses???

Additional good news

Confirmation of the safety and efficacy of Hydroxychloroquine as a valuable treatment for Covid-19 patients, as documented in two recent, scientifically impeccable, peer reviewed studies: One was published in the International Journal of Infectious DiseasesJuly 2, 2020, was conducted by a team of scientists led by Marcus Zevos, MD, head of Infectious Diseases for the Henry Ford Health System, examined the data of 2,541 hospitalized patients. Another study, published in the American Journal of Epidemiology, May 27th, 2020, was conducted by Harvey Risch, MD, PhD, an epidemiologist at Yale School of Public Health, who examined the data on outpatients treated with Hydroxychloroquine.

  • Both studies provide strong clinical evidence in support of the therapeutic value and legitimacy of using Hydroxychloroquine (HCQ), and HCQ in combination with azithromycin to treat patients with Covid-19.
  • The studies support a body of evidence, demonstrating that HCQ is clinically effective and has significantly reduced deaths – in both outpatients and hospitalized patients with Covid-19. The studies refute the orchestrated false Hydroxychloroquine narrative.

Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19 , Henry Ford Covid-19 Task Force headed by Dr. Marcus Zervos, International Journal of Infectious Diseases, July 2, 2020….

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.